A Phase 1 Study Consisting of a Double-Blind, Placebo Controlled Multiple Dose Study of TRx0037 in Healthy Elderly Volunteers
A Phase 1 Study Consisting of a Double-Blind, Placebo Controlled Multiple Dose Study of TRx0037 in Healthy Elderly Volunteers is a PHASE1 clinical asset sponsored by TauRx Therapeutics Ltd in Alzheimer's Disease. SEO and diligence focus: TRx0037, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Alzheimer's Disease
Modality: small molecule
Target: TRx0037
Sponsor: TauRx Therapeutics Ltd
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 24, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: TRx0037
View original source fields
Condition raw: Alzheimer's Disease
Condition normalized: Alzheimer's Disease
Modality raw: small molecule
Modality normalized: small molecule
Target raw: TRx0037
Target normalized: TRx0037